The paracrine properties of human amniotic membrane-derived mesenchymal stromal cells (hAMCs) have not been fully elucidated. The goal of the present study was to elucidate whether hAMCs can exert beneficial paracrine effects on infarcted rat hearts, in particular through cardioprotection and angiogenesis. Moreover, we aimed to identify the putative active paracrine mediators. hAMCs were isolated, expanded, and characterized. In vitro, conditioned medium from hAMC (hAMC-CM) exhibited cytoprotective and proangiogenic properties. In vivo, injection of hAMC-CM into infarcted rat hearts limited the infarct size, reduced cardiomyocyte apoptosis and ventricular remodeling, and strongly promoted capillary formation at the infarct border zone. Gene...
Background: Mesenchymal stem cells of fetal origin (F-MSCs) can be isolated from the amniotic membra...
Aims: A potential therapy for myocardial infarction is to deliver isolated stem cells to the infarct...
Myocardial infarction (MI) remains the leading cause of cardiovascular death worldwide and a major c...
The paracrine properties of human amniotic membrane-derived mesenchymal stromal cells (hAMCs) have n...
In recent years, various types of stem cells have been characterized and their potential for cardiac...
BACKGROUND: The adult mammalian heart retains residual regenerative capability via endogenous cardia...
Human amniotic epithelial cells (h-ABCs) have been shown to differentiate into cardiomyocyte-like ce...
Recent studies suggest that the therapeutic effects of stem cell transplantation following myocardia...
Human amniotic fluid stem cells (hAFS) are immature fetal mesenchymal progenitors with promising par...
Functional replacement of cardiomyocytes following injury represents a limiting aspect in cardiac r...
AbstractAlthough paracrine effects of mesenchymal stem cells (MSCs) have been suggested previously, ...
AbstractRecent studies suggest that the therapeutic effects of stem cell transplantation following m...
Human amniotic epithelial cells (h-AECs) have been shown to differentiate into cardiomyocyte-like ce...
Background: It has been shown that human bone marrow-derived mesenchymal stem cells (BM-MSC) repair ...
Introduction: Human amnion-derived mesenchymal stem cells (hAMSCs) have been used in the treatment o...
Background: Mesenchymal stem cells of fetal origin (F-MSCs) can be isolated from the amniotic membra...
Aims: A potential therapy for myocardial infarction is to deliver isolated stem cells to the infarct...
Myocardial infarction (MI) remains the leading cause of cardiovascular death worldwide and a major c...
The paracrine properties of human amniotic membrane-derived mesenchymal stromal cells (hAMCs) have n...
In recent years, various types of stem cells have been characterized and their potential for cardiac...
BACKGROUND: The adult mammalian heart retains residual regenerative capability via endogenous cardia...
Human amniotic epithelial cells (h-ABCs) have been shown to differentiate into cardiomyocyte-like ce...
Recent studies suggest that the therapeutic effects of stem cell transplantation following myocardia...
Human amniotic fluid stem cells (hAFS) are immature fetal mesenchymal progenitors with promising par...
Functional replacement of cardiomyocytes following injury represents a limiting aspect in cardiac r...
AbstractAlthough paracrine effects of mesenchymal stem cells (MSCs) have been suggested previously, ...
AbstractRecent studies suggest that the therapeutic effects of stem cell transplantation following m...
Human amniotic epithelial cells (h-AECs) have been shown to differentiate into cardiomyocyte-like ce...
Background: It has been shown that human bone marrow-derived mesenchymal stem cells (BM-MSC) repair ...
Introduction: Human amnion-derived mesenchymal stem cells (hAMSCs) have been used in the treatment o...
Background: Mesenchymal stem cells of fetal origin (F-MSCs) can be isolated from the amniotic membra...
Aims: A potential therapy for myocardial infarction is to deliver isolated stem cells to the infarct...
Myocardial infarction (MI) remains the leading cause of cardiovascular death worldwide and a major c...